Tech Company Financing Transactions

Avitide Funding Round

Borealis Ventures, Angeli Parvi and OrbiMed participated in a $1.4 million Series A capital raise for Avitide. The round was announced on 3/16/2013.

Transaction Overview

Company Name
Avitide
Announced On
3/16/2013
Transaction Type
Venture Equity
Amount
$1,449,999
Round
Series A
Investors

Borealis Ventures (Lead Investor) (Philip Ferneau)

Angeli Parvi

OrbiMed

Polaris Partners (Terry McGuire)

SV Health Investors (Michael Ross)

Proceeds Purpose
The proceeds from this financing will enable the further development of Avitide's custom affinity purification platform and continued commercial development of low cost and high capacity affinity resins for monoclonal antibodies, therapeutic proteins, and recombinant vaccines.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16 Cavendish Ct.
Lebanon, NH 03766
USA
Phone
(603) 965-2100
Website
www.avitide.com
Email Address
[email protected]
Overview
Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time.
Profile
Avitide LinkedIn Company Profile
Social Media
Avitide Company Twitter Account
Company News
Avitide News
Facebook
Avitide on Facebook
YouTube
Avitide on YouTube

Management Team

Title
Name
Email & Social
Chairman
Tillman Gerngross
  Tillman Gerngross LinkedIn Profile  Tillman Gerngross Twitter Account  Tillman Gerngross News  Tillman Gerngross on Facebook
Chief Executive Officer
Kevin Isett
  Kevin Isett LinkedIn Profile  Kevin Isett Twitter Account  Kevin Isett News  Kevin Isett on Facebook
Chief Financial Officer
Scott Kennedy
  Scott Kennedy LinkedIn Profile  Scott Kennedy Twitter Account  Scott Kennedy News  Scott Kennedy on Facebook
Chief Scientific Officer
Warren Kett
  Warren Kett LinkedIn Profile  Warren Kett Twitter Account  Warren Kett News  Warren Kett on Facebook
VP - Bus. Development
Daniel Freymeyer
  Daniel Freymeyer LinkedIn Profile  Daniel Freymeyer Twitter Account  Daniel Freymeyer News  Daniel Freymeyer on Facebook
VP - Engineering
Karol Lacki
  Karol Lacki LinkedIn Profile  Karol Lacki Twitter Account  Karol Lacki News  Karol Lacki on Facebook
VP - General Counsel
Kimberly Cornwell
  Kimberly Cornwell LinkedIn Profile  Kimberly Cornwell Twitter Account  Kimberly Cornwell News  Kimberly Cornwell on Facebook
VP - Manufacturing
Grant Espie
  Grant Espie LinkedIn Profile  Grant Espie Twitter Account  Grant Espie News  Grant Espie on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/16/2013: Arkadium venture capital transaction
Next: 3/16/2013: Front Desk venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.